Skip to main content

Articles

Page 239 of 335

  1. Gross cystic disease fluid protein 15 (GCDFP-15), which is regulated by the androgen receptor (AR), is a diagnostic marker for mammary differentiation in histopathology. We determined the expression of GCDFP-1...

    Authors: Silvia Darb-Esfahani, Gunter von Minckwitz, Carsten Denkert, Beyhan Ataseven, Bernhard Högel, Keyur Mehta, Gabriele Kaltenecker, Thomas Rüdiger, Berit Pfitzner, Kornelia Kittel, Bettina Fiedler, Klaus Baumann, Roland Moll, Manfred Dietel, Holger Eidtmann, Christoph Thomssen…
    Citation: BMC Cancer 2014 14:546
  2. The apoptosis inhibitor-5 (API5), anti-apoptosis protein, is considered a key molecule in the tumor progression and malignant phenotype of tumor cells. Here, we investigated API5 expression in cervical cancer,...

    Authors: Hanbyoul Cho, Joon-Yong Chung, Kwon-Ho Song, Kyung Hee Noh, Bo Wook Kim, Eun Joo Chung, Kris Ylaya, Jin Hee Kim, Tae Woo Kim, Stephen M Hewitt and Jae-Hoon Kim
    Citation: BMC Cancer 2014 14:545
  3. Seriously ill patients often depend on their informal caregivers to help and support them through the disease course. This study investigated informal cancer caregivers’ experiences of caregiving tasks and con...

    Authors: Line Lund, Lone Ross, Morten Aagaard Petersen and Mogens Groenvold
    Citation: BMC Cancer 2014 14:541
  4. Irreversible electroporation (IRE) has recently been added as an additional therapeutic ablative option in patients with locally advanced cancers (LAC) involving vital structures. IRE delivers localized electr...

    Authors: Robert CG Martin, Prejesh Philips, Susan Ellis, David Hayes and Sandeep Bagla
    Citation: BMC Cancer 2014 14:540
  5. Because oestrogen receptor α (ERα) regulates E2F1 expression to mediate tamoxifen resistance in ERα-positive breast cancer cells, we aimed to define the possible roles of ERα and E2F1 in promoting the resistan...

    Authors: María F Montenegro, María del Mar Collado-González, María Piedad Fernández-Pérez, Manel B Hammouda, Lana Tolordava, Mariam Gamkrelidze and José Neptuno Rodríguez-López
    Citation: BMC Cancer 2014 14:539
  6. Since the publication of two randomized controlled trials (RCT) in 1996 demonstrating the effectiveness of fecal occult blood test (FOBT) in reducing colorectal cancer (CRC) mortality, several public health in...

    Authors: Gladys N Honein-AbouHaidar, Linda Rabeneck, Lawrence F Paszat, Rinku Sutradhar, Jill Tinmouth and Nancy N Baxter
    Citation: BMC Cancer 2014 14:537
  7. The issue of a potential association between thyroid conditions/hormones and breast cancer has been studied extensively during the last decades but the results have been inconclusive and almost no studies have...

    Authors: Ada Tosovic, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson and Jonas Manjer
    Citation: BMC Cancer 2014 14:536
  8. New disease mapping techniques widely used in small-area studies enable disease distribution patterns to be identified and have become extremely popular in the field of public health. This paper reports on tre...

    Authors: Gonzalo López-Abente, Nuria Aragonés, Beatriz Pérez-Gómez, Marina Pollán, Javier García-Pérez, Rebeca Ramis and Pablo Fernández-Navarro
    Citation: BMC Cancer 2014 14:535
  9. Tryptase is a serine protease released from mast cells that plays a role in tumor angiogenesis. In this study we aimed to evaluate serum tryptase levels in 105 female early breast cancer patients before (STLBS...

    Authors: Ilaria Marech, Michele Ammendola, Rosario Sacco, Gennaro Stefano Capriuolo, Rosa Patruno, Rosangela Rubini, Maria Luposella, Valeria Zuccalà, Eufemia Savino, Cosmo Damiano Gadaleta, Domenico Ribatti and Girolamo Ranieri
    Citation: BMC Cancer 2014 14:534
  10. Ionizing radiation (IR) is a mainstay of cancer therapy, but irradiation can at times also lead to stress responses, which counteract IR-induced cytotoxicity. IR also triggers cellular secretion of vascular en...

    Authors: Colette J Shen, Ashish Sharma, Dinh-Van Vuong, Janine T Erler, Martin Pruschy and Angela Broggini-Tenzer
    Citation: BMC Cancer 2014 14:532
  11. Post-translational modification of histone tails by methylation plays an important role in tumorigenesis. In this study, we investigated the nuclear expression of H3K4me3, H3K9me3 and H4K20me3 in early-stage c...

    Authors: Anne Benard, Inès J Goossens-Beumer, Anneke Q van Hoesel, Wouter de Graaf, Hamed Horati, Hein Putter, Eliane CM Zeestraten, Cornelis JH van de Velde and Peter JK Kuppen
    Citation: BMC Cancer 2014 14:531
  12. Lenvatinib (E7080), an oral multi-kinase inhibitor, has inhibitory action on tumor cell proliferation and tumor angiogenesis in preclinical models. We evaluated correlations between pharmacodynamic (PD) biomar...

    Authors: Noriyuki Koyama, Kenichi Saito, Yuki Nishioka, Wataru Yusa, Noboru Yamamoto, Yasuhide Yamada, Hiroshi Nokihara, Fumiaki Koizumi, Kazuto Nishio and Tomohide Tamura
    Citation: BMC Cancer 2014 14:530
  13. Breast cancer is rarely diagnosed in very young women (35years old or younger), and it often presents with distinct clinical-pathological features related to a more aggressive phenotype and worse prognosis whe...

    Authors: Maria Peña-Chilet, Maria T Martínez, Jose A Pérez-Fidalgo, Lorena Peiró-Chova, Sara S Oltra, Eduardo Tormo, Elisa Alonso-Yuste, Beatriz Martinez-Delgado, Pilar Eroles, Joan Climent, Octavio Burgués, Jaime Ferrer-Lozano, Ana Bosch, Ana Lluch and Gloria Ribas
    Citation: BMC Cancer 2014 14:529
  14. Prostate cancer screening among the general population is highly debatable. Nevertheless, screening among high-risk groups is appealing. Prior data suggests that men carrying mutations in the BRCA1& 2 genes ma...

    Authors: David Margel, Ofer Benjaminov, Rachel Ozalvo, Liat Shavit Grievink, Inbal Kedar, Rinat Yerushalmi, Irit Ben-Aharon, Victoria Neiman, Ofer Yossepowitch, Daniel Kedar, Zohar Levy, Mordechai Shohat, Baruch Brenner, Jack Baniel and Eli Rosenbaum
    Citation: BMC Cancer 2014 14:528
  15. Metals including iron, copper and zinc are essential for physiological processes yet can be toxic at high concentrations. However the role of these metals in the progression of cancer is not well defined. Here...

    Authors: Maamoun Fatfat, Raghida Abou Merhi, Omar Rahal, Detcho A Stoyanovsky, Angela Zaki, Hazar Haidar, Valerian E Kagan, Hala Gali-Muhtasib and Khaled Machaca
    Citation: BMC Cancer 2014 14:527
  16. In this retrospective study, the authors evaluated the prognostic value of whole-body total lesion glycolysis (WTLG) on FDG/PET images in metastatic breast cancer (MBC) patients.

    Authors: Yoko Satoh, Atsushi Nambu, Tomoaki Ichikawa and Hiroshi Onishi
    Citation: BMC Cancer 2014 14:525
  17. 3,3′-diindolylmethane (DIM) is an acid-catalyzed dimer of idole-3-carbinol (I3C), a phytochemical found in cruciferous vegetables that include broccoli, Brussels sprouts and cabbage. DIM is an aryl hydrocarbon...

    Authors: Maud Marques, Liette Laflamme, Ines Benassou, Coumba Cissokho, Benoit Guillemette and Luc Gaudreau
    Citation: BMC Cancer 2014 14:524
  18. Succinate dehydrogenase subunit B (SDHB) mutations are associated with aggressive pheochromocytoma (PHEO)/paraganglioma (PGL) behavior, often resulting in metastatic disease and fatal outcomes. These tumors are o...

    Authors: Jan Schovanek, Victoria Martucci, Robert Wesley, Tito Fojo, Jaydira del Rivero, Thanh Huynh, Karen Adams, Electron Kebebew, Zdenek Frysak, Constantine A Stratakis and Karel Pacak
    Citation: BMC Cancer 2014 14:523
  19. It is largely accepted that specific immunological parameters in solid malignancies are associated with patient’s prognosis. Recently a correlation of macrophage polarization with histomorphological parameters...

    Authors: Falk Wehrhan, Maike Büttner-Herold, Peter Hyckel, Patrick Moebius, Raimund Preidl, Luitpold Distel, Jutta Ries, Kerstin Amann, Christian Schmitt, Friedrich W Neukam and Manuel Weber
    Citation: BMC Cancer 2014 14:522
  20. The FOLFOXIRI regimen (irinotecan, oxaliplatin, fluorouracil [5-FU] and folinic acid [FA]) increased the response rate and overall survival compared to FOLFIRI in patients with metastatic colorectal cancer (mC...

    Authors: Gunnar Folprecht, Susanne Hamann, Katharina Schütte, Tanja Trarbach, Jan Stoehlmacher-Williams and Gerhard Ehninger
    Citation: BMC Cancer 2014 14:521
  21. Since patients diagnosed with BRAF V600E and V600K mutated advanced melanoma show response to treatment with MAP kinase inhibitors, several sensitive methods have been developed to determine the V600 allele st...

    Authors: Julie Marchant, Alain Mange, Marion Larrieux, Valérie Costes and Jérôme Solassol
    Citation: BMC Cancer 2014 14:519
  22. Colorectal cancer is the third most frequently diagnosed cancer and the third cause of cancer deaths in the United States. Despite the fact that tumor cell-intrinsic mechanisms controlling colorectal carcinoge...

    Authors: Alexandra Naba, Karl R Clauser, Charles A Whittaker, Steven A Carr, Kenneth K Tanabe and Richard O Hynes
    Citation: BMC Cancer 2014 14:518
  23. Indigenous Australians have lower overall cancer survival which has not yet been fully explained. To address this knowledge deficit, we investigated the associations between comorbidities, cancer treatment and...

    Authors: Suzanne P Moore, Adèle C Green, Freddie Bray, Gail Garvey, Michael Coory, Jennifer Martin and Patricia C Valery
    Citation: BMC Cancer 2014 14:517
  24. Mucosal melanomas represent about 1% of all melanoma cases and classically have a worse prognosis than cutaneous melanomas. Due to the rarity of mucosal melanomas, only limited clinical studies with metastatic...

    Authors: Chung-Young Kim, Dae Won Kim, Kevin Kim, Jonathan Curry, Carlos Torres-Cabala and Sapna Patel
    Citation: BMC Cancer 2014 14:516
  25. Dose-dense sequential chemotherapy including anthracyclines and taxanes has been established in the adjuvant setting of high-risk operable breast cancer. However, the preferable taxane and optimal schedule of ...

    Authors: George Fountzilas, Urania Dafni, Christos Papadimitriou, Eleni Timotheadou, Helen Gogas, Anastasia G Eleftheraki, Ioannis Xanthakis, Christos Christodoulou, Angelos Koutras, Christos N Papandreou, Pavlos Papakostas, Spyros Miliaras, Christos Markopoulos, Constantine Dimitrakakis, Panagiotis Korantzopoulos, Charisios Karanikiotis…
    Citation: BMC Cancer 2014 14:515
  26. Disseminated tumor cells (DTCs) have potential to predict the effect of adjuvant treatment. The purpose of this study was to compare two methods, reverse transcription quantitative PCR (RT-qPCR) and immunocyto...

    Authors: Bjørnar Gilje, Oddmund Nordgård, Kjersti Tjensvoll, Elin Borgen, Marit Synnestvedt, Rune Smaaland and Bjørn Naume
    Citation: BMC Cancer 2014 14:514
  27. The electronic self report assessment - cancer (ESRA-C), has been shown to reduce symptom distress during cancer therapy The purpose of this analysis was to evaluate aspects of how the ESRA-C intervention may ...

    Authors: Donna L Berry, Fangxin Hong, Barbara Halpenny, Anne Partridge, Erica Fox, Jesse R Fann, Seth Wolpin, William B Lober, Nigel Bush, Upendra Parvathaneni, Dagmar Amtmann and Rosemary Ford
    Citation: BMC Cancer 2014 14:513
  28. To prospectively assess circulating tumor cell (CTC) status at baseline (CTCBL) and after one cycle of a new line of systemic therapy (CTC1C), and changes from CTCBL to CTC1C (CTC kinetics, CTCKIN) for their util...

    Authors: Markus Wallwiener, Sabine Riethdorf, Andreas Daniel Hartkopf, Caroline Modugno, Juliane Nees, Dharanija Madhavan, Martin Ronald Sprick, Sarah Schott, Christoph Domschke, Irène Baccelli, Birgitt Schönfisch, Barbara Burwinkel, Frederik Marmé, Jörg Heil, Christof Sohn, Klaus Pantel…
    Citation: BMC Cancer 2014 14:512
  29. New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O6-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have...

    Authors: Jaime Antonio Oliver, Raúl Ortiz, Consolación Melguizo, Pablo Juan Álvarez, Jaime Gómez-Millán and Jose Prados
    Citation: BMC Cancer 2014 14:511
  30. Nintedanib is a potent, oral angiokinase inhibitor that targets VEGF, PDGF and FGF signalling, as well as RET and Flt3. The maximum tolerated dose of nintedanib was evaluated in a phase I study of treatment-re...

    Authors: Klaus Mross, Martin Büchert, Annette Frost, Michael Medinger, Peter Stopfer, Matus Studeny and Rolf Kaiser
    Citation: BMC Cancer 2014 14:510
  31. Tetraspanins are transmembrane proteins that serve as scaffolds for multiprotein complexes containing, for example, integrins, growth factor receptors and matrix metalloproteases, and modify their functions in...

    Authors: Séverine Roselli, Richard GS Kahl, Ben T Copeland, Matthew J Naylor, Judith Weidenhofer, William J Muller and Leonie K Ashman
    Citation: BMC Cancer 2014 14:509
  32. Non-small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) need to be approached carefully given the high incidence of pulmonary toxicity. Pemetrexed (PEM) is the key drug for the treatme...

    Authors: Motoyasu Kato, Takehito Shukuya, Fumiyuki Takahashi, Keita Mori, Kentaro Suina, Tetsuhiko Asao, Ryota Kanemaru, Yuichiro Honma, Keiko Muraki, Koji Sugano, Rina Shibayama, Ryo Koyama, Naoko Shimada and Kazuhisa Takahashi
    Citation: BMC Cancer 2014 14:508
  33. Vinflunine (VFL) is a microtubule-targeting drug that suppresses microtubule dynamics, showing anti-metastatic properties both in vitro and in living cancer cells. An increasing body of evidence underlines the in...

    Authors: Luis A Aparicio, Raquel Castosa, Mar Haz-Conde, Marta Rodríguez, Moisés Blanco, Manuel Valladares and Angélica Figueroa
    Citation: BMC Cancer 2014 14:507
  34. Grade IV glioblastomas exist in two forms, primary (de novo) glioblastomas (pGBM) that arise without precursor lesions, and the less common secondary glioblastomas (sGBM) which develop from earlier lower grade le...

    Authors: Victoria K Hill, Thoraia Shinawi, Christopher J Ricketts, Dietmar Krex, Gabriele Schackert, Julien Bauer, Wenbin Wei, Garth Cruickshank, Eamonn R Maher and Farida Latif
    Citation: BMC Cancer 2014 14:506
  35. Few studies consider both the survival and financial benefits of detection of invasive cervical cancer (ICC) at earlier stages. This study estimated the savings in life-years and costs from early diagnosis of ...

    Authors: Mei-Chuan Hung, Meng-Ting Liu, Ya-Min Cheng and Jung-Der Wang
    Citation: BMC Cancer 2014 14:505
  36. The combination platinum, 5-fluorouracil (5-FU) and cetuximab is the standard first-line regimen of recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). Due to the toxicity of this treatm...

    Authors: Julien Péron, Valentine Polivka, Sylvie Chabaud, Marc Poupart, Philippe Ceruse, Antoine Ramade, Didier Girodet, Philippe Zrounba and Jérôme Fayette
    Citation: BMC Cancer 2014 14:504
  37. The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies. The ORHEO (place of biOsimilaRs in the ...

    Authors: Mauricette Michallet, Elisabeth Luporsi, Pierre Soubeyran, Nadia Ali Amar, Vincent Boulanger, Miguel Carreiro, Louis-Marie Dourthe, Jean-Luc Labourey, Daniel Lepille, Frédéric Maloisel, Jean-Loup Mouysset, Sophie Nahon, Bérengère Narciso, Pierre Nouyrigat, Raouf Radji, Nacéra Sakek…
    Citation: BMC Cancer 2014 14:503

    The Erratum to this article has been published in BMC Cancer 2014 14:720

  38. We previously showed that human papillomavirus (HPV) serostatus was not an independent risk factor for esophageal squamous cell carcinoma(ESCC) in nonsmokers and nondrinkers; however, HPV increased the risk in...

    Authors: Ju Yang, Huanlei Wu, Sheng Wei, Huihua Xiong, Xiangning Fu, Zhaozhen Qi, Qian Jiang, Wen Li, Guangyuan Hu, Xianglin Yuan and Zhongxing Liao
    Citation: BMC Cancer 2014 14:501
  39. At present, there are no widely accepted criteria for the use of radiofrequency ablation (RFA) for the treatment of colorectal liver metastases (CLM) in the context of effective modern-agent therapies. We aime...

    Authors: Axel Stang, Karl Jürgen Oldhafer, Hauke Weilert, Handan Keles and Marcello Donati
    Citation: BMC Cancer 2014 14:500
  40. The microenvironment modulates tissue specificity in the normal breast and in breast cancer. The stromal loss of CD34 expression and acquisition of SMA myofibroblastic features may constitute a prerequisite fo...

    Authors: Xavier Catteau, Philippe Simon and Jean-Christophe Noël
    Citation: BMC Cancer 2014 14:499
  41. Colorectal cancer (CRC) is the second most common malignancy in Europe and a leading cause of cancer-related death. Almost 50% of patients with CRC develop liver metastases, which heralds a poor prognosis unle...

    Authors: Susan J Dutton, Nicola Kenealy, Sharon B Love, Harpreet S Wasan and Ricky A Sharma
    Citation: BMC Cancer 2014 14:497
  42. Multiple myeloma is an incurable haematological cancer that affects physical, psychological and social domains of quality of life (QOL). Treatment decisions are increasingly guided by QOL issues, creating a ne...

    Authors: Thomas R Osborne, Christina Ramsenthaler, Susanne de Wolf-Linder, Stephen A Schey, Richard J Siegert, Polly M Edmonds and Irene J Higginson
    Citation: BMC Cancer 2014 14:496
  43. Growing evidence exists that the neoplastic stromal cell population (GCTSC) within giant cell tumors (GCT) originates from mesenchymal stem cells (MSC). In a previous study we identified a microRNA signature t...

    Authors: Burkhard Lehner, Pierre Kunz, Heiner Saehr and Joerg Fellenberg
    Citation: BMC Cancer 2014 14:495
  44. Podocalyxin (PODXL) is a transmembrane sialomucin, whose aberrant expression and/or allelic variation associates with poor prognosis and unfavourable clinicopathological characteristics in different cancers. M...

    Authors: Tuomas Kaprio, Jaana Hagström, Christian Fermér, Harri Mustonen, Camilla Böckelman, Olle Nilsson and Caj Haglund
    Citation: BMC Cancer 2014 14:494

Featured videos

View featured videos from across the BMC-series journals